Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

152520-56-4

Nebivolol HCl

152520-56-4
1325559-31-6

Nitroxinil Phenyl 13C6

1325559-31-6
51803-78-2

Nimesulide

51803-78-2
35189-28-7

Norgestimate

35189-28-7
42924-53-8

Nabumetone

42924-53-8
1216817-27-4

Dehydro Nicardipine Hydrochloride

1216817-27-4
985-16-0

Nafcillin Sodium Salt

985-16-0
79499-59-5

Norketamine HCl

79499-59-5
1435934-26-1

Norketamine-dehydro HCl

1435934-26-1
2398-81-4

Nicotinic acid N-oxide

2398-81-4
4409-34-1

17-epi-Nandrolone

4409-34-1
93-60-7

Methyl Nicotinate

93-60-7
88254-99-3

Netobimin Sodium Salt

88254-99-3
604-75-1

Oxazepam

604-75-1
82419-36-1

Ofloxacine

82419-36-1
7081-38-1

Oxyphenbutazone hydrate

7081-38-1
6153-64-6

Oxytetracycline 2H2O

6153-64-6
14698-29-4

Oxolinic acid

14698-29-4
2058-46-0

Oxytetracycline HCl

2058-46-0
88546-55-8

Omeprazole Sulfone

88546-55-8